Literature DB >> 14563924

An open conformation of mammalian cytochrome P450 2B4 at 1.6-A resolution.

Emily E Scott1, You Ai He, Michael R Wester, Mark A White, Christopher C Chin, James R Halpert, Eric F Johnson, C David Stout.   

Abstract

The xenobiotic metabolizing cytochromes P450 (P450s) are among the most versatile biological catalysts known, but knowledge of the structural basis for their broad substrate specificity has been limited. P450 2B4 has been frequently used as an experimental model for biochemical and biophysical studies of these membrane proteins. A 1.6-A crystal structure of P450 2B4 reveals a large open cleft that extends from the protein surface directly to the heme iron between the alpha-helical and beta-sheet domains without perturbing the overall P450 fold. This cleft is primarily formed by helices B' to C and F to G. The conformation of these regions is dramatically different from that of the other structurally defined mammalian P450, 2C5/3LVdH, in which the F to G and B' to C regions encapsulate one side of the active site to produce a closed form of the enzyme. The open conformation of 2B4 is trapped by reversible formation of a homodimer in which the residues between helices F and G of one molecule partially fill the open cleft of a symmetry-related molecule, and an intermolecular coordinate bond occurs between H226 and the heme iron. This dimer is observed both in solution and in the crystal. Differences between the structures of 2C5 and 2B4 suggest that defined regions of xenobiotic metabolizing P450s may adopt a substantial range of energetically accessible conformations without perturbing the overall fold. This conformational flexibility is likely to facilitate substrate access, metabolic versatility, and product egress.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563924      PMCID: PMC263748          DOI: 10.1073/pnas.2133986100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  A truncation of 2B subfamily cytochromes P450 yields increased expression levels, increased solubility, and decreased aggregation while retaining function.

Authors:  E E Scott; M Spatzenegger; J R Halpert
Journal:  Arch Biochem Biophys       Date:  2001-11-01       Impact factor: 4.013

Review 2.  Analysis of mammalian cytochrome P450 structure and function by site-directed mutagenesis.

Authors:  T L Domanski; J R Halpert
Journal:  Curr Drug Metab       Date:  2001-06       Impact factor: 3.731

3.  Probing the open state of cytochrome P450cam with ruthenium-linker substrates.

Authors:  A R Dunn; I J Dmochowski; A M Bilwes; H B Gray; B R Crane
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

4.  Purification and crystallization of N-terminally truncated forms of microsomal cytochrome P450 2C5.

Authors:  Michael R Wester; C David Stout; Eric F Johnson
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

5.  Membrane topology of cytochrome P450 2B4 in Langmuir-Blodgett monolayers.

Authors:  M L Shank-Retzlaff; G M Raner; M J Coon; S G Sligar
Journal:  Arch Biochem Biophys       Date:  1998-11-01       Impact factor: 4.013

6.  Identification of the binding site on cytochrome P450 2B4 for cytochrome b5 and cytochrome P450 reductase.

Authors:  A Bridges; L Gruenke; Y T Chang; I A Vakser; G Loew; L Waskell
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

7.  Interactions of substrate and product with cytochrome P450: P4502B4 versus P450cam.

Authors:  S Narasimhulu; L M Havran; P H Axelsen; J D Winkler
Journal:  Arch Biochem Biophys       Date:  1998-05-15       Impact factor: 4.013

Review 8.  Summary of information on human CYP enzymes: human P450 metabolism data.

Authors:  Slobodan Rendic
Journal:  Drug Metab Rev       Date:  2002 Feb-May       Impact factor: 4.518

9.  Amino acid residues critical for differential inhibition of CYP2B4, CYP2B5, and CYP2B1 by phenylimidazoles.

Authors:  M Spatzenegger; Q Wang; Y Q He; M R Wester; E F Johnson; J R Halpert
Journal:  Mol Pharmacol       Date:  2001-03       Impact factor: 4.436

10.  Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity.

Authors:  P A Williams; J Cosme; V Sridhar; E F Johnson; D E McRee
Journal:  Mol Cell       Date:  2000-01       Impact factor: 17.970

View more
  125 in total

1.  Substrate preferences and catalytic parameters determined by structural characteristics of sterol 14alpha-demethylase (CYP51) from Leishmania infantum.

Authors:  Tatiana Y Hargrove; Zdzislaw Wawrzak; Jialin Liu; W David Nes; Michael R Waterman; Galina I Lepesheva
Journal:  J Biol Chem       Date:  2011-05-31       Impact factor: 5.157

2.  Structural insights into inhibition of sterol 14alpha-demethylase in the human pathogen Trypanosoma cruzi.

Authors:  Galina I Lepesheva; Tatiana Y Hargrove; Spencer Anderson; Yuliya Kleshchenko; Vyacheslav Furtak; Zdzislaw Wawrzak; Fernando Villalta; Michael R Waterman
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

3.  Exploration of the binding of curcumin analogues to human P450 2C9 based on docking and molecular dynamics simulation.

Authors:  Rongwei Shi; Yin Wang; Xiaolei Zhu; Xiaohua Lu
Journal:  J Mol Model       Date:  2011-11-12       Impact factor: 1.810

4.  Thr302 is the site for the covalent modification of human cytochrome P450 2B6 leading to mechanism-based inactivation by tert-butylphenylacetylene.

Authors:  Hsia-lien Lin; Haoming Zhang; Matthew J Pratt-Hyatt; Paul F Hollenberg
Journal:  Drug Metab Dispos       Date:  2011-09-19       Impact factor: 3.922

5.  Cytochrome P450 flexibility.

Authors:  Thomas L Poulos
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

Review 6.  Conformational plasticity and structure/function relationships in cytochromes P450.

Authors:  Thomas C Pochapsky; Sophia Kazanis; Marina Dang
Journal:  Antioxid Redox Signal       Date:  2010-10       Impact factor: 8.401

7.  Three clusters of conformational states in p450cam reveal a multistep pathway for closing of the substrate access channel.

Authors:  Young-Tae Lee; Edith C Glazer; Richard F Wilson; C David Stout; David B Goodin
Journal:  Biochemistry       Date:  2011-01-11       Impact factor: 3.162

8.  Crystal structure of human cytochrome P450 2D6 with prinomastat bound.

Authors:  An Wang; Uzen Savas; Mei-Hui Hsu; C David Stout; Eric F Johnson
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

9.  A Minimal Functional Complex of Cytochrome P450 and FBD of Cytochrome P450 Reductase in Nanodiscs.

Authors:  Elke Prade; Mukesh Mahajan; Sang-Choul Im; Meng Zhang; Katherine A Gentry; G M Anantharamaiah; Lucy Waskell; Ayyalusamy Ramamoorthy
Journal:  Angew Chem Int Ed Engl       Date:  2018-06-14       Impact factor: 15.336

10.  Crystal structures of cytochrome P450 105P1 from Streptomyces avermitilis: conformational flexibility and histidine ligation state.

Authors:  Lian-Hua Xu; Shinya Fushinobu; Haruo Ikeda; Takayoshi Wakagi; Hirofumi Shoun
Journal:  J Bacteriol       Date:  2008-12-12       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.